2nd Quarter - Report

CAMERON KRIER MASSEY, INC. DBA SCOUT GR for TEXAS HOSPITAL ASSOCIATION

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

H.R. 1 - One Big Beautiful Bill Act. Expressed opposition to the following items being considered for a budget reconciliation package: capped Medicaid funding, restrictions on provider taxes, restrictions on state directed payment programs, site-neutral payment policies. Expressed support for delaying cuts to Medicaid Disproportionate Share hospitals, extending telehealth flexibilities, extending Medicare-related programs that support rural hospitals, and repealing the nursing home minimum staffing rule. Express support for Centers for Medicare and Medicaid Services (CMS) proposal to collect information from Medicare Advantage organizations (MAO) participating in the Medicare Advantage (MA) program; more specifically, the addition and clarification of data elements that will ensure CMS has appropriate insight into areas where patients and providers are struggling.

LobbyistCovered position, as disclosed
CAMERON KRIER MASSEY Legislative counsel for former US Senator Kay Bailey Hutchison

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1 (119th)

Health Issues HCR

Express support for extending enhanced premium tax credits set to expire end of year 2025. Express support for the No Surprises Enforcement Act (legislation to address surprise billing of patients for healthcare services). Responding to request for public comment by the Department of Justice to inform the Anticompetitive Regulations Task Force - provisions related to billing, privacy and security, quality and patient safety, telehealth, and workforce. Request for Department of Health and Human Services to deny drug companies requests to approve unlawful rebate models. Comments to Department of Commerce in response to Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients (XRIN 0694-XC120); expressing support for increasing domestic supply of pharmaceuticals and expressing concern about tariffs. Response to Office of Management and Budgets (OMB) request for information (RFI) on Deregulation (FR Doc. 2025-06316); comments specifically on billing, payment, and administrative burdens, privacy and security, quality and patient safety, telehealth, and workforce.

LobbyistCovered position, as disclosed
CAMERON KRIER MASSEY Former Legislative Counsel for Sen. Kay Bailey Hutchison

Contacted: Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Justice, Dept of (DOJ); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.